The global measured volume burette set market size is expected to reach USD 804.7 million by 2030, registering a CAGR of 7.1% from 2023 to 2030 according to a new report by Grand View Research, Inc., The burette sets are intended specifically for the gravity-based administration of precise volumes of infusion fluid. Burette sets with a flexible, clear, and calibrated measured volume container are infusion tools used for precise measurement. Burette chamber is scaled for precise medication measurement for treating chronic illness, newborn and pediatric treatment.
The growing global incidence of chronic diseases like cancer and diabetes is driving up demand for measured volumetric burettes. These devices are being adopted by hospitals and other healthcare institutions to provide patients with large volumes of medications and nutrients. Major life sciences and diagnostics companies like Thermo Fisher, B. Braun, Baxter, and others are also expected to support the market's expansion.
During the forecast period, the market is anticipated to be driven by the expanding use of measured volume burettes for paediatric or neonatal treatment. For treating paediatric patients, healthcare centers and other medical establishments commonly use volumetric burette infusion sets. When treating pediatric patients, the burette IV sets, which allow the provider to dispense a precise and controlled quantity of medicine, can be extremely important. Products like Dosifix, a device made available by Braun, are intended for use in treating paediatric and neonatal patients.
The global COVID-19 pandemic has caused numerous issues and disruptions around the globe. At first, this had a negative impact on the market for measured volume burette sets. The demand for different devices, however, has increased significantly in the healthcare industry as a result of patients needing better medical care. The global COVID-19 pandemic has resulted in the growing demand for measured volume burette set as most of the hospitalized patients, especially those in ICUs, are delivered medications through infusion pumps owing to their potential to provide accurate doses automatically at fixed duration. During the outbreak, this element fuels consumer demand for the product.
Request a free sample copy or view report summary: Measured Volume Burette Set Market Report
The 150 ml segment dominated the measured volume burette set market with a market share of 45.2% in 2022. The others segment includes the burettes with capacity volume of 50 ml, 25ml, 250 ml, and others.
North America dominated the global market in 2022 with a market share of 37.7%, owing to the higher adoption of technologically advancements products and increasing prevalence of chronic disorders in the region.
Hospitals segment is dominating the market in end-use segment as majority of the critical cases are treated in the hospitals, hence adoption of these devices is higher in the hospitals.
Grand View Research has segmented the global measured volume burette set market based on capacity, end-use, and region:
Measured Volume Burette Set Capacity Outlook (Revenue, USD Million, 2018 - 2030)
100 ml
110 ml
150 ml
Others
Measured Volume Burette Set End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Others
Measured Volume Burette Set Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Sweden
Denmark
Norway
Asia Pacific
India
China
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Measured Volume Burette Set Market
PL Medical
B. Braun
Baxter International, Inc.
Wellmed International Industries Pvt. Ltd.
Agniplast
Merck
Thermo Fisher
Globalmedikit
"The quality of research they have done for us has been excellent..."